ArticleCell reports. Medicine2024

PARP11 inhibition inactivates tumor-infiltrating regulatory T cells and improves the efficacy of immunotherapies.

Raghavendra Basavaraja et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.